Conditions: Diabetes Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 397
Healthy volunteers: no

Brief summary:
This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of semaglutide once weekly versus placebo as add-on to basal insulin alone or basal insulin in combination with metformin in subjects with type 2 diabetes.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: semaglutide intervention 2: placebo
Intervention descriptions: intervention 1: Injected subcutaneously (s.c. under the skin) once-weekly. As add-on to the pre-trial background medication. intervention 2: Injected subcutaneously (s.c. under the skin) once-weekly. As add-on to the pre-trial background medication.

Protocol document: